Tilray Brands Announces Runner’s High Brewing Company – Its New Brand of Premium Non-Alcoholic Brews
Runner’s High Brewing Taps into the Social Running CommunityNEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray...
News
Expanded Access to XHANCE with Addition to National Commercial Formularies
YARDLEY, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose...
Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced...
Monte Rosa Therapeutics Provides Development Progress Updates on MRT-2359 and MRT-6160
Ongoing Phase 1/2 Study of MRT-2359 for MYC-driven solid tumors demonstrates favorable safety and pharmacodynamic profile dosing 0.5 mg using...
Oculis and EURETINA Announces the Ramin Tadayoni Award
ZUG, Switzerland, June 27, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a...
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
Planegg/Martinsried, June 27, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on...
X4 Pharmaceuticals Announces Positive Interim Clinical Data from Ongoing Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) and Initiation of Pivotal Phase 3 CN Trial
100% of evaluable participants at Month 6 achieved target absolute neutrophil count (ANC) increase with once-daily, oral mavorixafor +/- stable-dose...
Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease
New VCIEL scale provides a more sensitive and quantitative metric of small intestinal health for monitoring Celiac Disease severity and...
GenVivo Announces Initiation of Patient Dosing in a US Phase I/Ib Clinical Trial Evaluating GEN2, a Personalizing, Gene Vector Immunotherapy, in Patients with Advanced Solid Tumors
GEN2’s dose-escalation trial, GVO-1102, will establish the Recommended Phase 2 Dose (RP2D), followed immediately by an expansion phase into 3...
Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications
Patient screening underway in Ntrust-1, the first U.S.-based clinical trial of an engineered NK cell therapy for the treatment of...
ANEW MEDICAL Forms Strategic Partnership with Japan’s Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene
Collaboration focuses on research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases ANEW’s...
Release Therapeutics Announces New CEO to Drive Best-in-Class CNS Innovation
The appointment aligns with the company’s recent strategic pivot towards treating genetic disorders of the CNS without gene therapyGENEVA, June...
Geek+ implements first Tote-to-Person project in Italy for pharmaceutical chain
DUSSELDORF, Germany, June 27, 2024 /PRNewswire/ -- Geekplus, the global leader in mobile robot and smart logistics solutions, in collaboration...
UNGUESS strengthens its international footprint by joining forces with Ferpection
Ferpection, a French company active in User Research since 2014, will join UNGUESS's orbit starting from the first half of...
PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO
Partner SMS Pharma will market the three products in the SiderAL® line under the trade name Sucrosom®, which is based on...
LabTrace Completes the First Study Using its Blockchain-Based Data Authentication System, Designed to Ensure Data Integrity in Clinical Trials
Parkinson's disease research, sponsored by King's College London, verifies clinical observation data using the Algorand blockchain LONDON, June 27, 2024...
Genflow Biosciences PLC Announces Strengthening of Pre-Clinical Efforts
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET...
Veterinary Software Market size is set to grow by USD 164.9 million from 2024-2028, Rising pet population to boost the market growth, Technavio
NEW YORK, June 26, 2024 /PRNewswire/ -- The global veterinary software market size is estimated to grow by USD 164.9 million...
The Mount Kisco Surgery Center LLC d/b/a The Ambulatory Surgery Center of Westchester -Notice of Data Security Incident
MOUNT KISCO, N.Y., June 26, 2024 /PRNewswire/ -- The Mount Kisco Surgery Center LLC d/b/a The Ambulatory Surgery Center of...
Ontinue Recognized as Finalist of 2024 Healthcare and Life Sciences Microsoft Partner of the Year
REDWOOD CITY, Calif., June 26, 2024 /PRNewswire/ -- Ontinue, a leading provider of AI-powered managed extended detection and response (MXDR) services...